A novel nonsense mutation in GCK exon 9 co-segregates with diabetes phenotype

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 6, 2004, Pages 298-301

  Knebel, B ^a   Jacob, S ^a   Boxberg, C V ^b   Müller Wieland, Dirk ^a   Kotzka, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Diabetische Schwerpunktpraxis L ^*  (Germany)

Author keywords

Glucokinase; Hepatocyte nuclear factor; Maturity onset diabetes of the young; Molecular diagnosis; Mutation

Indexed keywords

GLUCOKINASE; NUCLEAR FACTOR I;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; EXON; GENE; GENE SEGREGATION; GERMANY; GLUCOKINASE GENE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA GENE; HUMAN; INTRON; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONSENSE MUTATION; PRIORITY JOURNAL;

ANIMALS; CODON, NONSENSE; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; EXONS; FEMALE; GERMANY; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HETEROZYGOTE; MALE; NUCLEAR PROTEINS; PEDIGREE; PHENOTYPE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 3042807159     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-820967     Document Type: Article

References (20)

1. Bell GI, Polonsky KS. Diabetes mellitus and genetically programmed defects in b-cell function. Nature 2001; 414: 788-791
2. Bingham C, Nicholls AJ, Hatterslay AT. Heterogeneity in the clinical course of patients with type 2 diabetes on dialysis-the need for different preventative strategies. Diabet Med 2000; 17: 685-686
3. Byrne MM, Sturis J, Clement K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994; 93: 1120-1130
4. Ellard S. Hepatocyte nuclear factor alpha (HNF)-1α mutations in maturity-onset diabetes of the young. Human Mutation 2000; 16: 377-385
5. Frougel P, Vaxillaire M, Sun F, Vehlo G, Zouali H, Butel MO, Lesage S, Vionnet N, Clement K, Fougerousse F, Tanizawa Y, Weissenbach J, Beckmann JS, Lathrop GM, Passa P, Permutt MA, Cohen D. Close linkage of glucokinase locus on chromosome 7 p to early-onset non-insulin-dependant diabetes mellitus. Nature 1992; 356: 162-164
6. Frougel P, Zouali H, Vionnet N, Vehlo N, Vaxillaire M, Sun F, Leasage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckman JS, Bell GI, Cohen D. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328: 697-702
7. Gidh-Jain M, Takeda J, Xu LZ, Lange AJ, Vinonnet N, Stoffel M, Frougel P, Vehlo G, Sun F, Cohen D, Patel P, Lo Y-MD, Hatterslay AT, Luthman H, Wedell A, St Charles Rr, Harrison RW, Weber IT, Bell GI, Pilkis SJ. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci USA 1993; 90: 1932-1936
8. Gloyn AL. Glucokinase (GCK) mutations in hyper and hypoglycemia: Maturity-onset-diabetes of the young, permanent neonatal diabetes a hyperinsulinaemia of infancy. Human Mutation 2003; 22: 353-362
9. Hatterslay AT. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabetic Medicine 1998: 15: 15-24
10. Horikawa Y Iwasaki N Hara, Furuta H, Hinokio Y, Cockburn, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahar T, Iwamoto Y, Bell GI. Mutation in hepatocyte nuclear factor beta gene (TCF2) associated with MODY. Nature Genetics 1997; 17: 384-385
11. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montmini M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nature Genetics 1999; 23: 323-328
12. Matschinsky FM. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes 2002; 51 (Suppl 3): S394-S404
13. Ng MC, Li JK, So WY, Critchley JA, Cockram CS, Bell GI, Chan JC. Nature or nurture: an insightful illustration from a Chinese family with hepatocyte nuclear factor-1 alpha diabetes (MODY3). Diabetologia 2000; 43: 816-818
14. Sagan JV, Nojlstad PR, Sovik O. Reduced prevalence of late diabetic complications in MODY 3 with early diagnosis. Diabetic Medicine 2002; 19: 697-698
15. Stoffel M, Patel P, Lo YM, Hatterslay AT, Lucassen AM, Page R, Bell JI, Bell GI, Turner RC, Wainscoat JS. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late onset diabetes. Nature Genetics 1992; 2: 153-156
16. Stoffers DA, Ferrer J, Clarce WL, Habener JF. Early-onset type-II Diabetes melliuts (MODY 4) linked to IPF1. Nature Genetics 1997; 17: 138-139
17. Thomson KL, Gloyn AL, Colclough K, Batten M, Allen LIS, Beards F, Hatterslay AT, Ellard S. Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young. Human Mutation 2003; 22: 417
18. Velho G, Vaxillaire M, Bocchio V, Charpentier G, Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY 3 locus on chromosome 12 q. Diabetes Care 1996; 19: 915-919
19. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Coy NJ, Frajans SS, Signiorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor 4 alpha gene in maturilty-onset diabetes of the young (MODY 1). Nature 1996a; 384: 458-460.
20. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Frajans SS, Hatterslay AT, Iwasaki N, Pedersen O, Polonski KS, Turner RC, Vehlo G, Chevre J-C, Frougel P, Bell GI. Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996 b; 384: 455-458